Granules India Share Price Valuation Analysis April 2026
Comments Off on Granules India Share Price Valuation Analysis April 2026
Granules India — Zumedha Equity Research Zumedha Equity Research Initiating Coverage CMP ₹638 as on 17 Apr 2026 ACCUMULATE Granules India Ltd. Pharmaceuticals · Active Pharma Ingredients / Formulation Intermediates / Finished Dosages NSE…
Laurus Labs — DCF analysis March 2026
Comments Off on Laurus Labs — DCF analysis March 2026
Laurus Labs — Investment Research Report Zumedha Investment Research NSE: LAURUSLABS | BSE: 540222 29 March 2026 | Sector: Pharmaceuticals / CDMO LAURUSLABS CMP ₹984 52W Range ₹517 – ₹1,141 Mkt Cap ₹53,400 Cr P/E (TTM) ~65x…